AJIC: American Journal of Infection Control
Volume 37, Issue 3 , Pages 210-214 , April 2009

Cost of hospital-associated infections in Massachusetts

  • Patricia W. Stone, PhD, MPH, RN

      Affiliations

    • Columbia University School of Nursing, New York, NY
    • Corresponding Author InformationAddress correspondence to Patricia W. Stone, PhD, MPH, RN, Columbia University School of Nursing, 617 W 168th St, New York, NY 10032.
    • ,
  • Laureen Kunches, ANP, PhD

      Affiliations

    • JSI Research and Training Institute, Boston, MA
    • ,
  • Lisa Hirschhorn, MD, MPH

      Affiliations

    • JSI Research and Training Institute, Boston, MA

References 

  1. Pittet D, Donaldson L. Challenging the world: patient safety and health care–associated infection. Int J Qual Health Care. 2006;18:4–8
  2. Burke JP. Infection control: a problem for patient safety. N Engl J Med. 2003;348:651–656
  3. Martone WJ, Jarvis WR, Culver DH, Haley RW. Incidence and nature of endemic and epidemic nosocomial infections. In:  Bennett JV,  Brachman PS editor. Hospital infections. Boston: Little, Brown; 1992;p. 577–596
  4. Haley RW, Quade D, Freeman HE, Bennett JV for the SENIC Project. Study on the Efficacy of Nosocomial Infection Control (SENIC) Project: summary of study design. Am J Epidemiol. 1980;111:472–485
  5. Haley RW, Culver DH, White JW, Morgan WM, Emori TG, Munn VP, et al. The efficacy of infection surveillance and control programs in preventing nosocomial infections in US hospitals. Am J Epidemiol. 1985;121:182–205
  6. Haley RW. Managing hospital infection control for cost-effectiveness: a strategy for reducing infectious complications. Chicago: American Hospital Association, Inc; 1986;
  7. Scheckler WE, Brimhall D, Buck AS, Farr BM, Friedman C, Garibaldi RA, et al. Requirements for infrastructure and essential activities of infection control and epidemiology in hospitals: a consensus panel report. Society for Healthcare Epidemiology of America. Infect Control Hosp Epidemiol. 1998;19:114–124
  8. Klevens RM, Edwards JR, Richards C, Horan TC, Gaynes RP, Pollock DA, et al. Estimating health care–associated infections and deaths in US hospitals, 2002. Public Health Rep. 2007;122:160–166
  9. Centers for Disease Control and Prevention. The National Healthcare Safety Network (NHSN) user manual. Available from: http://www.edc.gov/ncidod/dhqp/pdf/nhsn/NHSN_Manual_%20Patient_Safety_Protocol022307.pdf. Accessed February 2, 2007.
  10. Perencevich EN, Stone PW, Wright SB, Carmeli Y, Fisman DN, Cosgrove SE. Raising standards while watching the bottom line: making a business case for infection control. Infect Control Hosp Epidemiol. 2007;28:1121–1133
  11. Stone PW, Larson E, Kawar LN. A systematic audit of economic evidence linking nosocomial infections and infection control interventions: 1990–2000. Am J Infect Control. 2002;30:145–152
  12. Stone PW, Braccia D, Larson E. Systematic review of economic analyses of health care–associated infections. Am J Infect Control. 2005;33:501–509
  13. Brossette SE, Hacek DM, Gavin PJ, Kamdar MA, Gadbois KD, Fisher AG, et al. A laboratory-based, hospital-wide, electronic marker for nosocomial infection: the future of infection control surveillance?. Am J Clin Pathol. 2006;125:34–39
  14. Dietrich ES, Demmler M, Schulgen G, Fekec K, Mast O, Pelz K, et al. Nosocomial pneumonia: a cost-of-illness analysis. Infection. 2002;30:61–67
  15. Hugonnet S, Eggimann P, Borst F, Maricot P, Chevrolet JC, Pittet D. Impact of ventilator-associated pneumonia on resource utilization and patient outcome. Infect Control Hosp Epidemiol. 2004;25:1090–1096
  16. Warren DK, Shukla SJ, Olsen MA, Kollef MH, Hollenbeak CS, Cox MJ, et al. Outcome and attributable cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical center. Crit Care Med. 2003;31:1312–1317
  17. Rello J, Ollendorf DA, Oster G, Vera-Llonch M, Bellm L, Redman R, et al. Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest. 2002;122:2115–2121
  18. Safdar N, Dezfulian C, Collard HR, Saint S. Clinical and economic consequences of ventilator-associated pneumonia: a systematic review. Crit Care Med. 2005;33:2184–2193
  19. Blot SI, Depuydt P, Annemans L, Benoit D, Hoste E, De Waele JJ, et al. Clinical and economic outcomes in critically ill patients with nosocomial catheter-related bloodstream infections. Clin Infect Dis. 2005;41:1591–1598
  20. Digiovine B, Chenoweth C, Watts C, Higgins M. The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit. Am J Respir Crit Care Med. 1999;160:976–981
  21. Rello J, Ochagavia A, Sabanes E, Roque M, Mariscal D, Reynaga E, et al. Evaluation of outcome of intravenous catheter–related infections in critically ill patients. Am J Respir Crit Care Med. 2000;162:1027–1030
  22. Babcock HM, Carroll C, Matava M, L'ecuyer P, Fraser V. Surgical site infections after arthroscopy: outbreak investigation and case control study. Arthroscopy. 2003;19:172–181
  23. de la Torre SH, Mandel L, Goff BA. Evaluation of postoperative fever: usefulness and cost-effectiveness of routine workup. Am J Obstet Gynecol. 2003;188:1642–1647
  24. Dietrich ES, Schubert B, Ebner W, Daschner F. Cost efficacy of tazobactam/piperacillin versus imipenem/cilastatin in the treatment of intra-abdominal infection. Pharmacoeconomics. 2001;19:79–94
  25. Engemann JJ, Carmeli Y, Cosgrove SE, Fowler VG, Bronstein MZ, Trivette SL, et al. Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin Infect Dis. 2003;36:592–598
  26. Hollenbeak CS, Murphy D, Dunagan WC, Fraser VJ. Nonrandom selection and the attributable cost of surgical site infections. Infect Control Hosp Epidemiol. 2002;23:177–182
  27. Perencevich EN, Sands KE, Cosgrove SE, Guadagnoli E, Meara E, Platt R. Health and economic impact of surgical site infections diagnosed after hospital discharge. Emerg Infect Dis. 2003;9:196–203
  28. Zhan C, Miller MR. Excess length of stay, charges, and mortality attributable to medical injuries during hospitalization. JAMA. 2003;290:1868–1874
  29. Whitehouse JD, Friedman ND, Kirkland KB, Richardson WJ, Sexton DJ. The impact of surgical-site infections following orthopedic surgery at a community hospital and a university hospital: adverse quality of life, excess length of stay, and extra cost. Infect Control Hosp Epidemiol. 2002;23:183–189
  30. Lai KK, Fontecchio SA. Use of silver-hydrogel urinary catheters on the incidence of catheter-associated urinary tract infections in hospitalized patients. Am J Infect Control. 2002;30:221–225
  31. Tambyah PA, Knasinski V, Maki DG. The direct costs of nosocomial catheter-associated urinary tract infection in the era of managed care. Infect Control Hosp Epidemiol. 2002;23:27–31
  32. Graves N, Halton K, Lairson D. Economics and preventing hospital-acquired infection: broadening the perspective. Infect Control Hosp Epidemiol. 2007;28:178–184
  33. Kilgore ML, Ghosh K, Beavers CM, Wong DY, Hymel PA, Brossette SE. The costs of nosocomial infections. Med Care. 2008;46:101–104
  34. Richards C, Emori TG, Edwards J, Fridkin S, Tolson J, Gaynes R. Characteristics of hospitals and infection control professionals participating in the National Nosocomial Infections Surveillance System 1999. Am J Infect Control. 2001;29:400–403

 Conflicts of interest: The authors report no conflicts of interest.

PII: S0196-6553(08)00752-9

doi: 10.1016/j.ajic.2008.07.011

AJIC: American Journal of Infection Control
Volume 37, Issue 3 , Pages 210-214 , April 2009

Article Tools